IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
Clinical trial NCT03744390 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03744390
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-02
- Primary completion
- 2023-02-18
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.